
Experience
Medically Home and DispatchHealth Close Merger
June 4, 2025
Cooley advised Medically Home, a provider of a hospital-at-home technology enablement model for health systems and physician groups to safely deliver emergency and hospital-level care at home, on its merger with DispatchHealth, a provider of high-acuity, in-home medical care for people experiencing serious health concerns.
Related contacts
Related Practices & Industries
Oberland Capital Invests up to $600 Million in Biohaven
April 28, 2025
Cooley advised Oberland Capital, a private investment firm committed to funding innovation across the global healthcare industry, on its agreement to invest up to $600 million in Biohaven (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases.
Related contacts
Related Practices & Industries
Tenet Medicines to Be Acquired by Eliem Therapeutics
April 11, 2024
Cooley advised Tenet Medicines, a development-stage private biotechnology company, on its definitive agreement to be acquired by Eliem Therapeutics, a biotech company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems.
Related contacts
Related Practices & Industries
Project Canary Closes $111 Million Series B Financing
June 8, 2022